The Canadian Psychedelic Businesses Association

We are
PsyCan

A not-for-profit trade association representing Canadian psychedelic medicine and therapy companies.

About Us

Press Release — Jan 29, 2025

Landmark International Collaboration Announced Between UK, Canadian, and US Psychedelic Industry Leaders

Read

Press Release — Aug 09, 2024

PsyCan Comments on FDA Decision Re: Lykos MDMA-Assisted Therapy Application

Read

Press Release — Apr 02, 2024

PsyCan Welcomes Expansion of Insurance Coverage for Psychedelic-Assisted Therapy in Alberta

Read

Psychedelics for mental health care

We champion the benefits of scientifically-proven, psychedelic-assisted therapies administered by qualified practitioners to Canadians suffering from chronic mental health conditions.

Newsroom

Advancing the psychedelics industry

We are dedicated to advocating on behalf of, and improving the regulatory landscape for, the legal psychedelics industry in Canada.

About us

Become a member

We represent researchers, medical practitioners, labs, clinics, drug developers, and suppliers producing and working with psychedelic medicine.

Membership

Leading the
charge for change

Our members are some of Canada’s industry leaders in pharmaceuticals, psychedelics, and mental health research. Together we seek to educate and better understand how psychedelics can improve mental health outcomes and well-being.

More about our members